Breast Cancer Research in Manchester

Nearly 48,000 women are diagnosed with breast cancer each year, making breast cancer the most commonly diagnosed cancer in the UK. Researching treatment and ways to prevent all types of the disease is the main aim of the Manchester Breast Centre. Some of this research is very specific, focusing on the unique characteristics of a particular form of breast cancer. However, much of our work will be of benefit to everyone with the disease.

The Manchester Breast Centre aims to promote collaborative working amongst breast cancer specialists in Manchester, underpinning the research that takes place and allowing access to a wide range of state of the art facilities. The Centre has grown from strength to strength since its launch in 2005 and continues to expand. Across the centre, world-class scientists and clinicians are working together to ensure their research makes as big an impact as possible, as fast as possible.

Manchester Firsts

We are sited in five major centres

Breast cancer research in Manchester is widespread and the Manchester Breast Centre (MBC) acts as a central point for both clinicians and non-clinicians specialising in this area. Collaboration is key to the success of the centre and its research. Since the amalgamation of the key breast research groups in Manchester in 2005, the MBC has continued to develop and expand. The centre is now sited in five major organisations in Manchester: The Nightingale Centre and Genesis Prevention Centre at University Hospital of South Manchester NHS Foundation Trust, The Christie NHS Foundation Trust, Paterson Institute for Cancer Research, Faculty of Life Sciences at The University of Manchester and St Mary’s Hospital at Central Manchester University Hospitals NHS Foundation Trust. There are also scientists and clinicians based at a number of other locations across Greater Manchester.